Notable is a clinical-stage platform therapeutics company developing predictive precision medicines for cancer patients. Through its proprietary Predictive Precision Medicines Platform or PPMP, Notable bio-simulates a patient’s cancer treatment ex vivo and seeks to precisely predict whether or not an individual patient will clinically respond to their actual treatment. In 4 independent clinical validation trials with recognized medical centers, PPMP predicted responders with 97% precision.